Synthesis of stereo (R and S) and geometric (E and Z) isomers of [18F]fluoro-β-fluoromethylene-m-tyrosine derivatives: In vivo probes of central dopaminergic function

Nuclear Medicine and Biology

Volumn 26, Issue 4, 1999, Pages 359-363

  Lacan, Goran ^a   Satyamurthy, N ^a   Barrio, Jorge R ^a  

^a Division of Nuclear Medicine   (United States)

Author keywords

Fluoromethylene m tyrosine; Dopaminergic function; Fluorination; Monoamine oxidase inhibitor; PET

Indexed keywords

BETA FLUOROMETHYLENE META TYROSINE; BETA FLUOROMETHYLENE META TYROSINE DERIVATIVE; FLUORINE 18; MONOAMINE OXIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DOPAMINE METABOLISM; DRUG ISOLATION; DRUG SYNTHESIS; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; STEREOISOMERISM;

BRAIN; DOPAMINE; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; MONOAMINE OXIDASE INHIBITORS; STEREOISOMERISM; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0032982476     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00006-2     Document Type: Article

References (27)

1. Abeles R.H., Maycock A.L. Suicide enzyme inactivators. Acc. Chem. Res. 9:1976;313-319.
2. Barrio J.R., Huang S.C., Phelps M.E. Biological imaging and the molecular basis of dopaminergic diseases. Biochem. Pharmacol. 54:1997;341-348.
3. Barrio J.R., Lacan G., Satyamurthy N., Yu D.C., Huang S.C., Phelps M.E. L-(E)-β-Fluoromethylene-6-[F-18]fluoro-m-tyrosine A specific central dopamine probe [abstract] . J. Nucl. Med. 34:1993;202P.
4. Bida G.T., Satyamurthy N., Barrio J.R. The synthesis of 2-[F-18]fluoro-2-deoxy-D-glucose using glycals A reexamination . J. Nucl. Med. 25:1984;1327-1334.
5. Craig J.C., Roy S.K. Optical rotatory dispersion and absolute configuration - I. α-Amino acids. Tetrahedron. 21:1965;391-394.
6. 18F]fluoro-β-fluoromethylene-m-tyrosine. Brain Res. 597:1992;151-154.
7. Dirkx I.P., Sixma F.L.J. Spectropolarimetry II. The optical rotatory dispersion of α-amino-acids and α-hydroxy-acids. Rec. Trav. Chim. 83:1964;522-534.
8. Fowden L., Scopes P.M., Thomas R.N. Optical rotatory dispersion and circular dichroism. Part LXX. The circular dichroism of some less common amino-acids. J. Chem. Soc. C:1971;833-840.
9. Hooker T.M. Jr, Schellman J.A. Optical activity of aromatic chromophores. I. o,m, and p-Tyrosine. Biopolymers. 9:1970;1319-1348.
10. 18F]Fluoro-β-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys. Nucl. Med. Biol. 26:1999;365-370.
11. Lacan G., Satyamurthy N., Barrio J.R. (E) and (Z)-β-fluoromethylene-m-tyrosines Resolution and determination of configuration . Tetrahedron: Asymmetry. 6:1995;525-536.
12. Lacan G., Satyamurthy N., Barrio J.R. Fluorination of (E)-β- (fluoromethylene)-m-tyrosine Regioselective synthesis of 4-fluoro-(E)-β-(fluoromethylene)-m-tyrosine . J. Org. Chem. 60:1995;227-234.
13. Lacan G., Satyamurthy N., Barrio J.R. (Z)-β-Fluoromethylene-m-tyrosine Synthesis, crystal structure and fluorination . J. Fluorine Chem. 74:1995;211-219.
14. McDonald I.A., Lacoste J.M., Bey P., Wagner J., Zreika M., Palfreyman M.G. Dual enzyme-activated irreversible inhibition of monoamine oxidase. Bioorg. Chem. 14:1986;103-118.
15. 18F]fluoro-L-m-tyrosine An L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography . J. Neurochem. 53:1989;311-314.
16. 18F]Fluoro-β-fluoromethylene-m-tyrosine analogs, potential PET agents for presynaptic dopamine terminals Synthesis and spectroscopic characterization . Appl. Radiat. Isot. 43:1992;969-977.
17. 18F]fluoro-L-dopa . Appl. Radiat. Isot. 43:1992;989-996.
18. 18F]fluoro-L-m-tyrosines via regioselective radiofluorodestannylation. Appl. Radiat. Isot. 44:1993;527-536.
19. Palfreyman M.G., Bey P., Sjoerdsma A. Enzyme-activated/mechanism-based inhibitors. Essays Biochem. 23:1987;28-81.
20. Palfreyman M.G., McDonald I.A., Bey P., Schechter P.J., Sjoerdsma A. Design and early clinical evaluation of selective inhibitors of monoamine oxidase. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 12:1988;967-987.
21. Palfreyman M.G., McDonald I.A., Fozard J.R., Mely Y., Sleight A.J., Zreika M., Wagner J., Bey P., Lewis P.J. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-β-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. J. Neurochem. 45:1985;1850-1860.
22. 18F]fluoro-L-m-tyrosine A model analog for the in vivo assessment of central dopaminergic function . Appl. Radiat. Isot. 41:1990;801-807.
23. Rando R.R. Mechanism-based enzyme inactivators. Pharmacol. Rev. 36:1984;111-142.
24. 18F]fluoromethylene-m-tyrosine derivatives, a dual enzyme activated inhibitor of monoamine oxidase [abstract]. J. Nucl. Med. 31:1990;1593.
25. Silverman R.B., Hoffman S.J. The organic chemistry of mechanism-based enzyme inhibition A chemical approach to drug design . Med. Res. Rev. 4:1984;415-447.
26. Tong J.H., Petitclerc C., D'Iorio A., Benoiton N.L. Resolution of ring-substituted phenylalanine by the action of α-chymotrypsin on their ethyl esters. Can. J. Biochem. 49:1971;877-881.
27. Walsh C.T. Suicide substrates, mechanism-based enzyme inactivators Recent developments . Ann. Rev. Biochem. 53:1984;493-535.